This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTCZ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,655.27 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through December 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Through this and other federal contract vehicles, AmerisourceBergen plays a critical role in supplying essential medical products to various government agencies, particularly within the military and veterans' healthcare systems.
Generated 3/14/25, 9:55 AM